BNTX | BioNTech SENASDAQADR golden cross and death cross projections, cross tests and history

$86.92
-$0.61 (-0.70%)

BioNTech SE (BNTX) is a NASDAQ-listed ADR that Cruxta has tracked for 50/200 crosses since 2022.

The 50 SMA has sat below the 200 on the daily since Nov 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $86.92 vs 50 $96.14 / 200 $96.89
Projection
No cross projected
Test
Cross test window open, no test bar yet
Last cross
Death cross 2 Nov 2026 ยท projected 15 bars out

Weekly as of 30 Oct 16:00 ET

Price
below both $88.17 vs 50 $97.13 / 200 $104.19
Projection
No cross projected
Test
No active test
Last cross
No cross on record

4-hour as of 3 Nov 16:00 ET

Price
below both $86.92 vs 50 $91.49 / 200 $94.95
Projection
No cross projected
Test
No active test
Last cross
Death cross 22 Oct 2026 ยท projected 18 bars out

Cross history

26
crosses on record since 2022
12 golden14 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
2 Nov 2026Death moderatedaily15 bars outActive Cross Test
22 Oct 2026Death4-hour18 bars outNot tested
23 Sep 2026Golden flatdaily14 bars out7 bar cross test
21 Aug 2026Golden4-hour4 bars outNot tested
27 Mar 2026Death moderatedaily11 bars outNot tested

About BNTX

ExchangeNASDAQ
InstrumentADR
Median $ volume, 60 d$97.1M
4-hour coverageYes, since Oct 2025
History on recordSince 2022
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.